SCHEMBL6965207

SCHEMBL6965207

Cn1ccc2cc(C[O])ccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.53
CYP2A6 P11509 2/20 0.53
CHRNA7 P36544 6/20 0.46
FAAH O00519 1/20 0.44
TRPV1 Q8NER1 1/20 0.41
HCRTR1 O43613 2/20 0.41
HCRTR2 O43614 2/20 0.41
CACNA1H O95180 2/20 0.41
PIK3CB P42338 1/20 0.41
HSD11B1 P28845 1/20 0.41
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40
TUBA4A P68366 1/20 0.40
TUBB4B P68371 1/20 0.40
TUBB3 Q13509 1/20 0.40
TUBB2A Q13885 1/20 0.40
TUBB8 Q3ZCM7 1/20 0.40
TUBA3E Q6PEY2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14361605 0.85 PRKCI (0.53) PRKCICYP2A6CHRNA7FAAHTRPV1
SCHEMBL8738295 0.82 PRKCI (0.55) PRKCICYP2A6CHRNA7FAAHTRPV1
SCHEMBL29263706 0.81 CYP2A6 (0.59) PRKCICYP2A6CHRNA7FAAHTRPV1
SCHEMBL25183109 0.81 PRKCI (0.53) PRKCICYP2A6CHRNA7FAAHTRPV1
SCHEMBL110146 0.81 PRKCI (0.58) PRKCICYP2A6CHRNA7FAAHTRPV1
SCHEMBL6965209 0.81 PRKCI (0.53) PRKCICYP2A6CHRNA7FAAHTRPV1
SCHEMBL18876154 0.79 PRKCI (0.52) PRKCICYP2A6CHRNA7FAAHTRPV1
SCHEMBL5094204 0.79 KDM4E (0.58) PRKCICYP2A6CHRNA7FAAHTRPV1
SCHEMBL6962451 0.78 RORC (0.46) FAAHTUBB4ATUBBTUBA3CTUBA1B
SCHEMBL20562931 0.78 PRKCI (0.59) PRKCICYP2A6CHRNA7FAAHHCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6642255-B2 Substituted carbocyclic or heterocyclic hydroxamic acid derivatives, e.g., (3R,4S)-N-hydroxy-1-methyl-3-(((4-((2-methyl-4 -quinolinyl)methoxylphenyl)sulfonyl)methyl)-4-piperidinecarboxamide BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-11-04 US disclosed
EP-1355648-A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) Bristol-Myers Squibb Pharma Company (US) 2003-10-29 EP disclosed
WO-2002055491-A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) BRISTOL MYERS SQUIBB COMPANY P (US) 2002-07-18 WO disclosed